Technology | May 07, 2014

FDA Clears GE’s Discovery IGS 740 Mobile Angiography System

System designed to meet needs of interventional radiology without limits of fixed-base systems

GE Healthcare Discovery IGS 740 Mobile Angiography System FDA Approval

May 7, 2014 — GE Healthcare received U.S. Food and Drug Administration (FDA) clearance for its Discovery IGS 740, a new rail-free mobile angiography system with a 41x41 cm detector. The Discovery IGS 740 is the first of this kind of mobile angiography system in the industry to receive FDA approval.

This new imaging system puts interventional radiologists at the center of their procedures. The rail-free design allows healthcare professionals ample access to the patient while freeing clinical teams from the constraints of fixed ceiling-mounted system rails. Its wide bore C-arm and dedicated arm-imaging positions create ease in imaging the anatomy of interest and full patient access from the left or right. A rotating laser continuously scans the room so the system knows where it is at all times.

By eliminating the ceiling rails, installation is simplified for flexibility in designing the room and positioning ceiling-mounted ancillaries (monitors, radshields, lights) where healthcare professionals need them.

The Discovery IGS 740 is equipped with two customizable parking positions to accommodate multiple room sizes and shapes. The 41x41-cm detector enables imaging of large organs, such as the liver and simultaneous coverage of both legs. The wide-bore C-arm helps interventional radiologists image large patients and conveniently perform off centered 3-D acquisitions. In addition, the system comes equipped with more than 20 advanced applications, such as FlightPlan for Liver, which helps clinicians identify tumor-feeding vessels in a few clicks, and be selective during liver embolizations.

For more information: newsroom.gehealthcare.com

Related Content

Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...
Society of Interventional Radiology Announces 2019 Gold Medalists
News | Interventional Radiology | April 08, 2019
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Alan H. Matsumoto, M....
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction
Technology | Radiation Dose Management | April 04, 2019
The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer their artificial...
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Interventional Radiology Treatment for Tennis Elbow Reduces Pain and Inflammation

Image courtesy of Yuji Okuno

News | Interventional Radiology | March 29, 2019
Tennis elbow, a painful chronic condition that affects up to 3 percent of U.S. adults, can be effectively treated...
New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019
Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...